Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 0 | 0 | 0 | 0 | 20,467 |
| Cost of Goods | -261 | -200 | -386 | 638 | 13,187 |
| Gross Profit | 261 | 200 | 386 | -638 | 7,281 |
| Operating Expenses | 392 | 612 | 568 | 1,219 | 1,110 |
| Operating Income | -131 | -413 | -182 | -1,858 | 6,171 |
| Other Income | -23 | 80 | 99 | 106 | 582 |
| Pre-tax Income | -154 | -332 | -83 | -1,752 | 6,753 |
| Income Tax | 51 | -86 | -22 | -456 | 1,613 |
| Net Income Continuous | -205 | -247 | -61 | -1,296 | 5,141 |
| Net Income | $-205 | $-247 | $-61 | $-1,296 | $5,141 |
| EPS Basic Total Ops | -0.02 | -0.01 | 0.00 | -0.06 | 0.26 |
| EPS Basic Continuous Ops | -0.02 | -0.01 | 0.00 | -0.06 | 0.26 |
| EPS Diluted Total Ops | -0.02 | -0.01 | 0.00 | -0.06 | 0.26 |
| EPS Diluted Continuous Ops | -0.02 | -0.01 | 0.00 | -0.06 | 0.26 |
| EBITDA(a) | $-131 | $-413 | $-182 | $-1,858 | $7,120 |